USGOW US quarterly earnings metrics are not yet available with investors awaiting fresh operational updates McEwen MUX Stock Is It Reasonably Valued Q4 2025 EPS Beats Forecasts RVPH Reviva reports narrower Q3 2025 loss versus analyst estimates shares edge up in daily trading NAMI Jinxin management outlines targeted AI service investments to support next phase of operational growth CGEN Compugen Q4 2025 EPS far outpaces estimates shares rise 231 percent on strong investor sentiment WRD WeRide shares gain 321 percent despite reporting a wider than expected Q4 2025 loss REFR Research shares fall 396 following Q2 2025 earnings release with no analyst consensus estimates available VMAR Vision blows past Q4 2025 earnings estimates shares climb 177 on strong investor optimism